Nextleaf Solutions Ltd. the world’s most progressive cannabis extractor, is happy to announce that the United States Patent and Trademark Office has granted the Company a patent to a way for refining uncooked cannabis plant materials, including to Nextleaf’s already sturdy and increasing U.S. patent portfolio.Nextleaf’s newest U.S. patent covers a way for separating cannabinoid-rich trichomes from decrease efficiency …
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most progressive cannabis extractor, is happy to announce that the United States Patent and Trademark Office has granted the Company a patent to a way for refining uncooked cannabis plant materials, including to Nextleaf’s already sturdy and increasing U.S. patent portfolio.
Nextleaf’s newest U.S. patent covers a way for separating cannabinoid-rich trichomes from decrease efficiency cannabis biomass, together with most accredited industrial hemp cultivars, which Nextleaf makes use of to extend the focus of CBD in hemp biomass. The Company’s patented expertise considerably will increase extraction effectivity and improves the economics of processing hemp into high-purity CBD extracts.
To view an enhanced model of Figure 1, please go to:
The Company owns 14 U.S. patents and has been issued over 70 patents globally for the extraction, purification, formulation, and supply of cannabinoids.
The first half of 2021 has been outlined by M&A and consolidation within the cannabis trade. Canada’s federally authorized and controlled cannabis framework has continued to draw vital funding from world tobacco and beverage alcohol corporations. On March 11, 2021 British American Tobacco acquired a 19.9% stake in an Atlantic Canada-based cannabis producer Organigram. As a part of the funding, British American Tobacco and Organigram agreed to determine a Centre of Excellence to collaborate on mental property and product improvement. This week, the Boston Beer Company, maker of Samuel Adams beer introduced it’s establishing a subsidiary in Canada to function a devoted analysis and innovation hub for non-alcoholic cannabis drinks.
“Global tobacco and alcohol giants have been investing in Canadian marijuana producers to understand regulated cannabis and generate IP to deploy into U.S. markets upon federal legalization,” stated Nextleaf Solutions Chief Executive Officer Paul Pedersen. “As one of the largest cannabis patent holders globally, Nextleaf Solutions is excited to see big tobacco and alcohol validate our intellectual property focused strategy. We have been building a moat around our technology, protecting the most efficient methods for producing standardized cannabinoids within a regulated market,” stated Pedersen. “With this latest issued U.S. patent, Nextleaf has protected competitively-advantaged technology vital to the low-cost production of high-purity CBD extracts.”
Nextleaf is an progressive cannabis processor that owns one of many largest portfolios of U.S. patents for the extraction, distillation, and supply of cannabinoids. Nextleaf provides cannabis oils to its wholesale prospects and distributes shopper merchandise beneath its award-winning prohibition-era model, Glacial Gold. Nextleaf’s proprietary closed-loop automated extraction plant in Metro Vancouver has a design capability to course of 600 kilos of dried cannabis into oil per day. Nextleaf is creating supply expertise by way of its Health Canada Research Licence with sensory analysis of cannabis by way of human testing.
The Company owns 14 U.S. patents and has been issued over 70 patents globally.
For extra data please contact:
604-283-2301 (ext. 219)
On behalf of the Board of Directors of the Company,
Paul Pedersen, CEO
Certain statements contained on this press launch represent “forward-looking statements”. All statements aside from statements of historic truth contained on this press launch, together with, with out limitation, these concerning the Company’s capacity to capitalize on its IP portfolio, the Company’s technique, plans, goals, objectives and targets, and any statements preceded by, adopted by or that embrace the phrases “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or comparable expressions or the adverse thereof, are forward-looking statements. These statements should not historic information however as a substitute signify solely the Company’s expectations, estimates and projections concerning future occasions. These statements should not ensures of future efficiency and contain assumptions, dangers and uncertainties which might be troublesome to foretell. Therefore, precise outcomes could differ materially from what’s expressed, implied or forecasted in such forward-looking statements. Additional components that would trigger precise outcomes, efficiency or achievements to vary materially embrace, however should not restricted to the danger components mentioned within the Company’s MD&A for the latest fiscal interval. Management offers forward-looking statements as a result of it believes they supply helpful data to buyers when contemplating their funding goals and cautions buyers to not place undue reliance on forward-looking data. Consequently, all the forward-looking statements made on this press launch are certified by these cautionary statements and different cautionary statements or components contained herein, and there might be no assurance that the precise outcomes or developments might be realized or, even when considerably realized, that they are going to have the anticipated penalties to, or results on, the Company. These forward-looking statements are made as of the date of this press launch and the Company assumes no obligation to replace or revise them to replicate subsequent data, occasions or circumstances or in any other case, besides as required by legislation. The CSE has not reviewed or accredited the contents of this press launch.
To view the supply model of this press launch, please go to https://www.newsfilecorp.com/release/84636